Who Owns BLRX?

BioLineRx Ltd. — Institutional Ownership & 13F Holdings

$2.90

-0.17 (-5.54%)

Market Cap

$11.5M

Shares Outstanding

4,351,350

Institutional Holders

11

Total Inst. Value

$26K

% of Float Held

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1WELLS FARGO & COMPANY/MN$9K3,000
2BNP PARIBAS FINANCIAL MARKETS$5K1,748
3MORGAN STANLEY$5K2,244
4RHUMBLINE ADVISERS$5K1,530
5JPMORGAN CHASE & CO$1K375
6Nemes Rush Group LLC$888300
7NewEdge Advisors, LLC$317107
8GROUP ONE TRADING LLC$23479
9UBS Group AG$21071
10SBI Securities Co., Ltd.$62

Related Stocks

Frequently Asked Questions

How many institutional investors hold BLRX?

As of Q1 2025, 11 institutional investors report holding BLRX (BioLineRx Ltd.) in their 13F filings.

Which hedge fund owns the most BLRX?

The largest institutional holder of BLRX is WELLS FARGO & COMPANY/MN with $9K in shares.

Are institutions buying or selling BLRX?

This quarter, 11 institutions opened new positions in BLRX and 1 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.